nodes	percent_of_prediction	percent_of_DWPC	metapath
Clorazepate—CYP3A4—Everolimus—kidney cancer	0.203	0.293	CbGbCtD
Clorazepate—CYP3A4—Temsirolimus—kidney cancer	0.137	0.198	CbGbCtD
Clorazepate—CYP3A4—Pazopanib—kidney cancer	0.072	0.104	CbGbCtD
Clorazepate—CYP3A4—Erlotinib—kidney cancer	0.0514	0.0741	CbGbCtD
Clorazepate—Blood pressure systolic decreased—Paclitaxel—kidney cancer	0.0472	0.161	CcSEcCtD
Clorazepate—CYP3A4—Paclitaxel—kidney cancer	0.047	0.0678	CbGbCtD
Clorazepate—CYP3A4—Sorafenib—kidney cancer	0.0418	0.0603	CbGbCtD
Clorazepate—CYP3A4—Vinblastine—kidney cancer	0.0413	0.0595	CbGbCtD
Clorazepate—CYP3A4—Vincristine—kidney cancer	0.0406	0.0585	CbGbCtD
Clorazepate—CYP3A4—Sunitinib—kidney cancer	0.0338	0.0488	CbGbCtD
Clorazepate—CYP3A4—Doxorubicin—kidney cancer	0.0253	0.0366	CbGbCtD
Clorazepate—Haematocrit decreased—Paclitaxel—kidney cancer	0.0119	0.0409	CcSEcCtD
Clorazepate—Irritability—Everolimus—kidney cancer	0.0055	0.0188	CcSEcCtD
Clorazepate—Vision blurred—Pazopanib—kidney cancer	0.00414	0.0142	CcSEcCtD
Clorazepate—Dysarthria—Capecitabine—kidney cancer	0.00386	0.0132	CcSEcCtD
Clorazepate—Ataxia—Vincristine—kidney cancer	0.00383	0.0131	CcSEcCtD
Clorazepate—Dry mouth—Pazopanib—kidney cancer	0.00366	0.0125	CcSEcCtD
Clorazepate—Insomnia—Temsirolimus—kidney cancer	0.00344	0.0118	CcSEcCtD
Clorazepate—Somnolence—Temsirolimus—kidney cancer	0.00338	0.0116	CcSEcCtD
Clorazepate—Fatigue—Temsirolimus—kidney cancer	0.00328	0.0112	CcSEcCtD
Clorazepate—Vision blurred—Everolimus—kidney cancer	0.00327	0.0112	CcSEcCtD
Clorazepate—Tremor—Everolimus—kidney cancer	0.00325	0.0111	CcSEcCtD
Clorazepate—Insomnia—Pazopanib—kidney cancer	0.00324	0.0111	CcSEcCtD
Clorazepate—Somnolence—Pazopanib—kidney cancer	0.00319	0.0109	CcSEcCtD
Clorazepate—Fatigue—Pazopanib—kidney cancer	0.00309	0.0106	CcSEcCtD
Clorazepate—Ataxia—Paclitaxel—kidney cancer	0.00304	0.0104	CcSEcCtD
Clorazepate—Dry mouth—Everolimus—kidney cancer	0.00289	0.00987	CcSEcCtD
Clorazepate—Fenbufen—PTGS1—kidney cancer	0.00289	0.202	CrCbGaD
Clorazepate—Asthenia—Temsirolimus—kidney cancer	0.00273	0.00934	CcSEcCtD
Clorazepate—Diplopia—Capecitabine—kidney cancer	0.00265	0.00907	CcSEcCtD
Clorazepate—Asthenia—Pazopanib—kidney cancer	0.00257	0.0088	CcSEcCtD
Clorazepate—Insomnia—Everolimus—kidney cancer	0.00256	0.00875	CcSEcCtD
Clorazepate—Irritability—Capecitabine—kidney cancer	0.00253	0.00866	CcSEcCtD
Clorazepate—Somnolence—Everolimus—kidney cancer	0.00252	0.0086	CcSEcCtD
Clorazepate—Dizziness—Temsirolimus—kidney cancer	0.00252	0.0086	CcSEcCtD
Clorazepate—Oxaprozin—PTGS1—kidney cancer	0.00251	0.176	CrCbGaD
Clorazepate—Dry mouth—Sorafenib—kidney cancer	0.00251	0.00857	CcSEcCtD
Clorazepate—Ataxia—Capecitabine—kidney cancer	0.00249	0.00853	CcSEcCtD
Clorazepate—Dysarthria—Doxorubicin—kidney cancer	0.00249	0.00851	CcSEcCtD
Clorazepate—Insomnia—Erlotinib—kidney cancer	0.00247	0.00845	CcSEcCtD
Clorazepate—Fatigue—Everolimus—kidney cancer	0.00244	0.00834	CcSEcCtD
Clorazepate—Dry mouth—Sunitinib—kidney cancer	0.00241	0.00825	CcSEcCtD
Clorazepate—Rash—Temsirolimus—kidney cancer	0.0024	0.0082	CcSEcCtD
Clorazepate—Dermatitis—Temsirolimus—kidney cancer	0.0024	0.0082	CcSEcCtD
Clorazepate—Headache—Temsirolimus—kidney cancer	0.00238	0.00815	CcSEcCtD
Clorazepate—Dizziness—Pazopanib—kidney cancer	0.00237	0.00811	CcSEcCtD
Clorazepate—Fatigue—Erlotinib—kidney cancer	0.00235	0.00805	CcSEcCtD
Clorazepate—Feeling abnormal—Vinblastine—kidney cancer	0.00234	0.00801	CcSEcCtD
Clorazepate—Feeling abnormal—Everolimus—kidney cancer	0.00233	0.00798	CcSEcCtD
Clorazepate—Rash—Pazopanib—kidney cancer	0.00226	0.00773	CcSEcCtD
Clorazepate—Dermatitis—Pazopanib—kidney cancer	0.00226	0.00772	CcSEcCtD
Clorazepate—Headache—Pazopanib—kidney cancer	0.00225	0.00768	CcSEcCtD
Clorazepate—Insomnia—Sunitinib—kidney cancer	0.00214	0.00731	CcSEcCtD
Clorazepate—Fatigue—Sorafenib—kidney cancer	0.00212	0.00724	CcSEcCtD
Clorazepate—Asthenia—Vinblastine—kidney cancer	0.00204	0.00697	CcSEcCtD
Clorazepate—Fatigue—Sunitinib—kidney cancer	0.00204	0.00697	CcSEcCtD
Clorazepate—Asthenia—Everolimus—kidney cancer	0.00203	0.00694	CcSEcCtD
Clorazepate—Asthenia—Erlotinib—kidney cancer	0.00196	0.0067	CcSEcCtD
Clorazepate—Fatigue—Dactinomycin—kidney cancer	0.00193	0.0066	CcSEcCtD
Clorazepate—Tension—Paclitaxel—kidney cancer	0.00191	0.00653	CcSEcCtD
Clorazepate—Nervousness—Paclitaxel—kidney cancer	0.00189	0.00646	CcSEcCtD
Clorazepate—Dizziness—Vinblastine—kidney cancer	0.00188	0.00643	CcSEcCtD
Clorazepate—Dizziness—Everolimus—kidney cancer	0.00187	0.0064	CcSEcCtD
Clorazepate—Feeling abnormal—Dactinomycin—kidney cancer	0.00184	0.00631	CcSEcCtD
Clorazepate—Vision blurred—Paclitaxel—kidney cancer	0.00183	0.00627	CcSEcCtD
Clorazepate—Tremor—Paclitaxel—kidney cancer	0.00182	0.00623	CcSEcCtD
Clorazepate—Insomnia—Vincristine—kidney cancer	0.00181	0.00618	CcSEcCtD
Clorazepate—Dizziness—Erlotinib—kidney cancer	0.00181	0.00618	CcSEcCtD
Clorazepate—Rash—Everolimus—kidney cancer	0.00178	0.0061	CcSEcCtD
Clorazepate—Dermatitis—Everolimus—kidney cancer	0.00178	0.0061	CcSEcCtD
Clorazepate—Headache—Vinblastine—kidney cancer	0.00178	0.00609	CcSEcCtD
Clorazepate—Headache—Everolimus—kidney cancer	0.00177	0.00606	CcSEcCtD
Clorazepate—Asthenia—Sorafenib—kidney cancer	0.00176	0.00603	CcSEcCtD
Clorazepate—Fatigue—Vincristine—kidney cancer	0.00172	0.0059	CcSEcCtD
Clorazepate—Rash—Erlotinib—kidney cancer	0.00172	0.00589	CcSEcCtD
Clorazepate—Dermatitis—Erlotinib—kidney cancer	0.00172	0.00588	CcSEcCtD
Clorazepate—Insomnia—Gemcitabine—kidney cancer	0.00172	0.00587	CcSEcCtD
Clorazepate—Headache—Erlotinib—kidney cancer	0.00171	0.00585	CcSEcCtD
Clorazepate—Diplopia—Doxorubicin—kidney cancer	0.00171	0.00585	CcSEcCtD
Clorazepate—Asthenia—Sunitinib—kidney cancer	0.0017	0.0058	CcSEcCtD
Clorazepate—Somnolence—Gemcitabine—kidney cancer	0.00169	0.00577	CcSEcCtD
Clorazepate—Fenbufen—PTGS2—kidney cancer	0.00165	0.116	CrCbGaD
Clorazepate—Fatigue—Gemcitabine—kidney cancer	0.00164	0.00559	CcSEcCtD
Clorazepate—Dizziness—Sorafenib—kidney cancer	0.00162	0.00556	CcSEcCtD
Clorazepate—Dry mouth—Paclitaxel—kidney cancer	0.00162	0.00554	CcSEcCtD
Clorazepate—Ataxia—Doxorubicin—kidney cancer	0.00161	0.0055	CcSEcCtD
Clorazepate—Asthenia—Dactinomycin—kidney cancer	0.00161	0.00549	CcSEcCtD
Clorazepate—Confusional state—Paclitaxel—kidney cancer	0.0016	0.00548	CcSEcCtD
Clorazepate—Dizziness—Sunitinib—kidney cancer	0.00156	0.00535	CcSEcCtD
Clorazepate—Feeling abnormal—Gemcitabine—kidney cancer	0.00156	0.00535	CcSEcCtD
Clorazepate—Rash—Sorafenib—kidney cancer	0.00155	0.0053	CcSEcCtD
Clorazepate—Dermatitis—Sorafenib—kidney cancer	0.00155	0.00529	CcSEcCtD
Clorazepate—Headache—Sorafenib—kidney cancer	0.00154	0.00526	CcSEcCtD
Clorazepate—Vision blurred—Capecitabine—kidney cancer	0.00151	0.00515	CcSEcCtD
Clorazepate—Tremor—Capecitabine—kidney cancer	0.0015	0.00512	CcSEcCtD
Clorazepate—Rash—Sunitinib—kidney cancer	0.00149	0.0051	CcSEcCtD
Clorazepate—Dermatitis—Sunitinib—kidney cancer	0.00149	0.00509	CcSEcCtD
Clorazepate—Headache—Sunitinib—kidney cancer	0.00148	0.00506	CcSEcCtD
Clorazepate—Insomnia—Paclitaxel—kidney cancer	0.00144	0.00491	CcSEcCtD
Clorazepate—Asthenia—Vincristine—kidney cancer	0.00143	0.00491	CcSEcCtD
Clorazepate—Oxaprozin—PTGS2—kidney cancer	0.00143	0.101	CrCbGaD
Clorazepate—Somnolence—Paclitaxel—kidney cancer	0.00141	0.00483	CcSEcCtD
Clorazepate—Rash—Dactinomycin—kidney cancer	0.00141	0.00483	CcSEcCtD
Clorazepate—Fatigue—Paclitaxel—kidney cancer	0.00137	0.00468	CcSEcCtD
Clorazepate—Asthenia—Gemcitabine—kidney cancer	0.00136	0.00465	CcSEcCtD
Clorazepate—Flurbiprofen—PTGS1—kidney cancer	0.00135	0.0948	CrCbGaD
Clorazepate—Dry mouth—Capecitabine—kidney cancer	0.00133	0.00455	CcSEcCtD
Clorazepate—Dizziness—Vincristine—kidney cancer	0.00132	0.00452	CcSEcCtD
Clorazepate—Drowsiness—Doxorubicin—kidney cancer	0.00132	0.0045	CcSEcCtD
Clorazepate—Confusional state—Capecitabine—kidney cancer	0.00131	0.00449	CcSEcCtD
Clorazepate—Feeling abnormal—Paclitaxel—kidney cancer	0.00131	0.00448	CcSEcCtD
Clorazepate—Rash—Vincristine—kidney cancer	0.00126	0.00431	CcSEcCtD
Clorazepate—Dermatitis—Vincristine—kidney cancer	0.00126	0.00431	CcSEcCtD
Clorazepate—Headache—Vincristine—kidney cancer	0.00125	0.00428	CcSEcCtD
Clorazepate—Rash—Gemcitabine—kidney cancer	0.0012	0.00409	CcSEcCtD
Clorazepate—Dermatitis—Gemcitabine—kidney cancer	0.00119	0.00409	CcSEcCtD
Clorazepate—Headache—Gemcitabine—kidney cancer	0.00119	0.00406	CcSEcCtD
Clorazepate—Insomnia—Capecitabine—kidney cancer	0.00118	0.00403	CcSEcCtD
Clorazepate—Asthenia—Paclitaxel—kidney cancer	0.00114	0.0039	CcSEcCtD
Clorazepate—Fatigue—Capecitabine—kidney cancer	0.00112	0.00384	CcSEcCtD
Clorazepate—Feeling abnormal—Capecitabine—kidney cancer	0.00107	0.00367	CcSEcCtD
Clorazepate—Dizziness—Paclitaxel—kidney cancer	0.00105	0.00359	CcSEcCtD
Clorazepate—Tension—Doxorubicin—kidney cancer	0.00101	0.00345	CcSEcCtD
Clorazepate—Rash—Paclitaxel—kidney cancer	0.001	0.00342	CcSEcCtD
Clorazepate—Dermatitis—Paclitaxel—kidney cancer	0.001	0.00342	CcSEcCtD
Clorazepate—Nervousness—Doxorubicin—kidney cancer	0.001	0.00342	CcSEcCtD
Clorazepate—Headache—Paclitaxel—kidney cancer	0.000995	0.0034	CcSEcCtD
Clorazepate—Vision blurred—Doxorubicin—kidney cancer	0.00097	0.00332	CcSEcCtD
Clorazepate—Asthenia—Capecitabine—kidney cancer	0.000935	0.0032	CcSEcCtD
Clorazepate—Dizziness—Capecitabine—kidney cancer	0.000862	0.00295	CcSEcCtD
Clorazepate—Dry mouth—Doxorubicin—kidney cancer	0.000857	0.00293	CcSEcCtD
Clorazepate—Confusional state—Doxorubicin—kidney cancer	0.000847	0.0029	CcSEcCtD
Clorazepate—Rash—Capecitabine—kidney cancer	0.000822	0.00281	CcSEcCtD
Clorazepate—Dermatitis—Capecitabine—kidney cancer	0.000821	0.00281	CcSEcCtD
Clorazepate—Headache—Capecitabine—kidney cancer	0.000816	0.00279	CcSEcCtD
Clorazepate—Flurbiprofen—PTGS2—kidney cancer	0.000773	0.0542	CrCbGaD
Clorazepate—Insomnia—Doxorubicin—kidney cancer	0.00076	0.0026	CcSEcCtD
Clorazepate—Somnolence—Doxorubicin—kidney cancer	0.000747	0.00255	CcSEcCtD
Clorazepate—Diazepam—PTGS1—kidney cancer	0.000737	0.0517	CrCbGaD
Clorazepate—Fatigue—Doxorubicin—kidney cancer	0.000724	0.00248	CcSEcCtD
Clorazepate—Feeling abnormal—Doxorubicin—kidney cancer	0.000692	0.00237	CcSEcCtD
Clorazepate—Clozapine—CYP1A1—kidney cancer	0.000666	0.0467	CrCbGaD
Clorazepate—Clobazam—ABCB1—kidney cancer	0.000614	0.0431	CrCbGaD
Clorazepate—Asthenia—Doxorubicin—kidney cancer	0.000603	0.00206	CcSEcCtD
Clorazepate—Dizziness—Doxorubicin—kidney cancer	0.000556	0.0019	CcSEcCtD
Clorazepate—Rash—Doxorubicin—kidney cancer	0.00053	0.00181	CcSEcCtD
Clorazepate—Dermatitis—Doxorubicin—kidney cancer	0.000529	0.00181	CcSEcCtD
Clorazepate—Headache—Doxorubicin—kidney cancer	0.000526	0.0018	CcSEcCtD
Clorazepate—Nitrazepam—ABCB1—kidney cancer	0.000507	0.0356	CrCbGaD
Clorazepate—Midazolam—ABCB1—kidney cancer	0.000418	0.0293	CrCbGaD
Clorazepate—Diazepam—ABCB1—kidney cancer	0.000358	0.0251	CrCbGaD
Clorazepate—Clozapine—ABCB1—kidney cancer	0.000354	0.0248	CrCbGaD
